Cancer Genes and Genomics Role of Neuro fi lament Light Polypeptide in Head and Neck Cancer Chemoresistance

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrating biomarkers into clinical trials: methodological issues for a new paradigm in nonsmall cell lung cancer

  2011cited by this paper
• Head and neck cancer in 2010: Maximizing survival and minimizing toxicity

  2011cited by this paper
• How the projection domains of NF-L and α-internexin determine the conformations of NF-M and NF-H in neurofilaments

  2010cited by this paper
• A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer

  2010cited by this paper
• mTOR: from growth signal integration to cancer, diabetes and ageing

  2010cited by this paper
• Neurofilament Heavy Polypeptide Regulates the Akt-β-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma

  2010cited by this paper
• Identification of hypermethylated genes associated with cisplatin resistance in human cancers.

  2010cited by this paper
• beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.

  2009cited by this paper
• Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.

  2009cited by this paper
• Current concepts for the management of head and neck cancer: chemotherapy.

  2009cited by this paper
• Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

  2009cited by this paper
• mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

  2009influential reference
• Elevated Expression of Glutathione S-Transferase π and p53 Confers Poor Prognosis in Head and Neck Cancer Patients Treated with Chemoradiotherapy but not Radiotherapy Alone

  2008cited by this paper
• Cisplatin‐mediated activation of extracellular signal‐regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases

  2008cited by this paper
• Molecularly targeted agents in the treatment of recurrent or metastatic squamous cell carcinomas of the head and neck.

  2008cited by this paper
• How do real tumors become resistant to cisplatin?

  2008cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.

  2007cited by this paper
• Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease

  2007cited by this paper
• LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.

  2007cited by this paper
• N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

  2006influential reference
• Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

  2006influential reference
• Chemoresistance in non-small cell lung cancer.

  2005cited by this paper
• Aberrant gene silencing in tumor progression: implications for control of cancer.

  2005cited by this paper
• Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.

  2005cited by this paper
• Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing

  2004cited by this paper
• Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl‐2 expression and increased susceptibility to cisplatin‐induced apoptosis

  2004cited by this paper
• Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma

  2004cited by this paper
• A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.

  2004cited by this paper
• Enhanced sensitivity of prostate cancer DU145 cells to cisplatinum by 5-aza-2'-deoxycytidine.

  2004cited by this paper
• Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve.

  2003cited by this paper
• Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.

  2003cited by this paper
• Differentially expressed genes associated with CIS‐diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray

  2003cited by this paper
• The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.

  2003cited by this paper
• Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

  2003cited by this paper
• The TSC1 Tumor Suppressor Hamartin Interacts with Neurofilament-L and Possibly Functions as a Novel Integrator of the Neuronal Cytoskeleton*

  2002influential reference
• Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

  2002cited by this paper
• Mammalian Target of Rapamycin (mTOR): Pro- and Anti-Apoptotic

  2002cited by this paper
• Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters.

  2000cited by this paper
• Fine deletion mapping of chromosome 8p in non‐small‐cell lung carcinoma

  1999cited by this paper
• Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.

  1999cited by this paper
• Splice Variant-Specific Interaction of the NMDA Receptor Subunit NR1 with Neuronal Intermediate Filaments

  1998cited by this paper
• Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines

  1997cited by this paper
• Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.

  1995cited by this paper
• Thymidylate synthase activity, folates, and glutathione system in head and neck carcinoma and adjacent tissues

  1994cited by this paper
• Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.

  1993cited by this paper

• No citing papers are available for this paper.